y # 2 Genoslim: A Genetic Obesity Drug
Strategy # 3: Breast Cancer Home Testing
Strategy # 4 - Backtrack: Cartilage Transplant
In the sections that follow, MDMM will be applied to each of these strategic alternatives. A weighted scale will be applied to each of the attributes. The scale will run from 50 points for "Very Important" to 10 for "Inconsequential."
Strategy #1: Acquisition of IDEC Pharmaceuticals
In order to guarantee future growth and increase product development and decrease time to market, Roche Holdings is determining the risks/rewards of acquiring IDEC Pharmaceutical.
There are more long-term benefits than short-term, since the profitability is expected in long-term earnings than in immediate stock appreciation. An indirect consideration is that since Roche owes its stockholders a consistent commitment to research, then the acquisition of IDEC would maintain that commitment while ensuring growth and independence, cover ri
...